Welcome to the LAL-D Patient Organization (LAL-D PO), the international organization for patients and families affected by Lysosomal Acid Lipase Deficiency (LAL-D).
Our goal is to support families, raise awareness of the disease, advance research, and promote early diagnosis, which is key to saving lives and improving patients’ quality of life.
Since 2015, we have been working to ensure that no one affected by LAL-D feels alone.
LAL‑D Study – Phase 3
LAL‑D Study – Phase 3 the University of Rochester (USA) is currently conducting Phase 3 of its research project on Lysosomal Acid Lipase Deficiency (LAL‑D). Our organization is not conducting this study, but we would like to help share this opportunity and...
Genetic liver diseases: rare, but clinically highly relevant
Genetic liver diseases: rare, but clinically highly relevant This article highlights that genetic liver diseases, while individually uncommon, represent a significant and often underdiagnosed cause of chronic liver disease in adults. Detection is particularly...
en‑LISOS Journal – Issue No. 9, March 2026
en‑LISOS Journal – Issue No. 9, March 2026 en‑LISOS has published its Issue 9 (March 2026), featuring scientific and informative content focused on lysosomal diseases. In this issue, LAL‑D Patient Organization has contributed with an article written by Eduardo...
